Skip to content

US · CRVL · INSURANCE - BROKERS

CorVel Corporation (CRVL) intrinsic value and stock valuation

$88.28as of 2026-11-21 · Mkt cap 3.19B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

CorVel Corporation DCF and intrinsic value

InvestorsCraft values CRVL with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from CRVL’s statements →

CorVel Corporation Graham Number

Graham Number: $19.29d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Financial Services · Insurance - Brokers Fort Worth, TX 76109 corvel.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$958.5M+11.6% 5y CAGRd
20122026
Net income
$110.3M+18.9% 5y CAGRd
20122026
Free cash flow
$110.3M+7.4% 5y CAGRd
20122026
Total equity
$394.2M+12.3% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$958.5M$895.6M$795.3M$718.6M$646.2M
Operating income$143.1M$120.8M$95.1M$84.6M$84.5M
Net income$110.3M$95.2M$76.3M$66.4M$66.4M
EPSd$2.14M$1.83M$1.47M$1.26M$1.22M
Operating cash flow$155.6M$127.3M$99.2M$82.3M$67.2M
Capital expenditure-$-45.36M-$-35.76M-$-29.24M-$-26.32M-$-29.82M
Free cash flow$110.3M$91.6M$70M$56M$37.4M
Total assets$643M$546M$454.7M$393.9M$415.3M
Total debt$28.1M$28.1M$31.4M$33.8M$43.1M
Net debt-$-204.97M-$-142.5M-$-74.17M-$-37.57M-$-54.36M
Total equity$394.2M$322M$247.7M$202.2M$212.4M
Cash and short-term investments$233.1M$170.6M$105.6M$71.3M$97.5M
Income statement
20262025202420232022
Revenue$958.5M$895.6M$795.3M$718.6M$646.2M
Cost of revenue$725.7M$685.9M$623.6M$560.3M$494.1M
Gross profit$232.9M$209.7M$171.7M$158.3M$152.1M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$89.7B$88.9M$76.6M$73.7M$67.6M
Other expenses-$-89.64B$0.00$0.00$0.00$0.00
Operating expenses$89.7M$88.9M$76.6M$73.7M$67.6M
Cost and expenses$815.4M$774.8M$700.2M$634M$561.7M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$31.8M$29.5M$26.3M$25.1M$23.9M
Ebitda$174.9M$150.4M$121.4M$109.7M$108.4M
Operating income$143.1M$120.8M$95.1M$84.6M$84.5M
Total other income/expenses, net$0.00$0.00$0.00$0.00$0.00
Income before tax$143.1M$120.8M$95.1M$84.6M$84.5M
Income tax expense$32.8M$25.7M$18.9M$18.2M$18.1M
Net income$110.3M$95.2M$76.3M$66.4M$66.4M
Weighted average shares outstanding$51.3M$51.4M$51.4M$52M$53.3M
Weighted average diluted shares outstanding$51.6M$52M$52M$52.8M$54.4M
Balance sheet
20262025202420232022
Cash and short-term investments$233.1M$170.6M$105.6M$71.3M$97.5M
Net receivables$101.3M$104.1M$97.1M$81M$82.6M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$462.3M$386.7M$302.2M$243.8M$265M
Property, plant and equipment, net$139.1M$112.9M$110M$110.5M$111.3M
Goodwill and intangible assets$37.1M$37.3M$37.6M$38.1M$38.5M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$180.7M$159.3M$152.5M$150.2M$150.3M
Total assets$643M$546M$454.7M$393.9M$415.3M
Accounts payable$24.3M$15.4M$16.4M$15.1M$14.1M
Short-term debt$7.42M$8.13M$8.86M$9.9M$13.4M
Deferred revenue$147.9M$132.3M$118.1M$107M$95.6M
Total current liabilities$228.1M$204M$184.5M$167.9M$171.4M
Long-term debt$20.7M$20M$22.5M$23.9M$29.8M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$20.7M$20M$22.5M$23.9M$31.5M
Capital lease obligations$28.1M$28.1M$31.4M$33.8M$43.1M
Total liabilities$248.8M$224M$207M$191.8M$202.9M
Common stock$10K$10K$0.00$0.00$0.00
Retained earnings$1.01B$903.1M$807.9M$731.7M$665.3M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$394.2M$322M$247.7M$202.2M$212.4M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$28.1M$28.1M$31.4M$33.8M$43.1M
Net debt-$-204.97M-$-142.5M-$-74.17M-$-37.57M-$-54.36M
Cash flow statement
20262025202420232022
Net income$110.3M$95.2M$76.3M$66.4M$66.4M
Depreciation and amortization$31.8M$29.5M$26.3M$25.1M$23.9M
Stock-based compensation$5.41M$5.71M$4.98M$5.56M$5.2M
Change in working capital$2.52M-$-1.83M-$-7.05M-$-14.47M-$-30.88M
Accounts receivable$2.7M-$-10.46M-$-17.9M$340K-$-18.02M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-730K$0.00$0.00$0.00$0.00
Net cash provided by operating activities$155.6M$127.3M$99.2M$82.3M$67.2M
Investments in property, plant and equipment-$-45.36M-$-35.76M-$-29.24M-$-26.32M-$-29.82M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-45.36M-$-35.76M-$-29.24M-$-26.32M-$-29.82M
Common stock issued$8.41M$0.00$0.00$0.00$0.00
Common stock repurchased-$-56.21M-$-37.6M-$-45.71M-$-93.67M-$-90.08M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-47.8M-$-26.54M-$-35.76M-$-82.14M-$-79.61M
Net change in cash$62.5M$65M$34.2M-$-26.18M-$-42.21M
Cash at end of period$233.1M$170.6M$105.6M$71.3M$97.5M
Operating cash flow$155.6M$127.3M$99.2M$82.3M$67.2M
Capital expenditure-$-45.36M-$-35.76M-$-29.24M-$-26.32M-$-29.82M
Free cash flow$110.3M$91.6M$70M$56M$37.4M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About CorVel Corporation

        CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.

        CEO
        Sarah Scott
        Employees
        5.24K
        Beta
        0.98

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of CorVel Corporation (CRVL)?

        InvestorsCraft does not currently publish an intrinsic value for CRVL. How the IC value is calculated.

        Is CRVL undervalued?

        InvestorsCraft does not publish an undervaluation signal for CRVL at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.